BRENDAN SUHR: Open Payments
NPI 1932819638 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 65 payments from 20 companies in 2025. Trend: 2023 $1,330 · 2024 $1,287 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $542 |
| AstraZeneca Pharmaceuticals LP | 7 | $265 |
| ABBVIE INC. | 11 | $184 |
| Lilly USA, LLC | 6 | $107 |
| PFIZER INC. | 5 | $88 |
| Astellas Pharma US Inc | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Exact Sciences Corporation | 1 | $29 |
| Amgen Inc. | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: Ozempic, AIRSUPRA, BREZTRI, UBRELVY, Wegovy, MOUNJARO, ELIQUIS, Rybelsus.
Industry payments across FL — which companies pay providers there.
